Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evelo Biosciences

0.0005
+0.0000
Volume:- -
Turnover:- -
Market Cap:9.49K
PE:0.00
High:0.0005
Open:0.0005
Low:0.0005
Close:0.0005
Loading ...
May 11, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 27, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 28, 2020

Major Issues Report

Current report, item 5.02
Feb 14, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 13, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Dec 05, 2019

Major Issues Report

Current report, item 5.02
Nov 05, 2019

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Sep 18, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Aug 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 06, 2019

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Jul 24, 2019

Major Issues Report

Current report, items 1.01, 1.02, 2.03, and 9.01
Jul 11, 2019

Major Issues Report

Current report, item 1.01
Jun 14, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 14, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jun 14, 2019

Major Issues Report

Current report, item 5.02
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities